News

News

LNC Therapeutics becomes YSOPIA Bioscience marking its transition to a clinical stage company

Sep 29, 2020

more +
News

LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...

Sep 8, 2020

more +
News

LNC Therapeutics announces the acquisition of an exclusive worldwide license on the first patent...

Apr 15, 2020

more +
News

LNC Therapeutics Announces Successful GMP Manufacturing of Xla1 for Phase 1 Clinical Trial

Mar 12, 2020

more +
News

LNC Therapeutics and the National Institute for Agricultural Research (INRA) sign research...

Dec 11, 2019

more +
News

LNC Therapeutics Announces Formation of its Scientific Advisory Board

Nov 5, 2019

more +

YSOPIA Bioscience © 2023 - all rights reserved terms and conditions